drugset / Trial / NCT01306123

Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration

NCT01306123

Phase 1 Completed 16 enrolled Swedish Orphan Biovitrum
RandomizedCrossoverOpen-labelTreatment

Summary

The main purpose of this study is to assess the relative bioavailability of Nascobal Nasal Spray as compared to an IM injection of cyanocobalamin (European reference product).

Timeline

Start
2011-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin B12 Other / unclassified Intranasal

Indications

No indication recorded.